Matthew E. Burow
Impact in
- Oncology top 0.5%
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
- Immunology top 0.5%
- T-cell and B-cell Immunology
- Immunotherapy and Immune Responses
- Immune cells in cancer
Papers in
-
- Breast Cancer Treatment Studies 18
- MicroRNA in disease regulation 11
- Oncology 45
- Cancer Cells and Metastasis 33
- Co-authors
- John A. McLachlan (48 shared papers)Barbara S. Beckman (36 shared papers)Bridgette M. Collins‐Burow (69 shared papers)Steven G. Elliott (44 shared papers)Lyndsay V. Rhodes (33 shared papers)Bruce Alan Bunnell (32 shared papers)Christopher Bertero Weldon (14 shared papers)Stephen M. Boué (28 shared papers)
- Journals
- Breast Cancer Research (7 papers)Journal of Agricultural and Food Chemistry (7 papers)Breast Cancer Research and Treatment (6 papers)Cancer Research (5 papers)PLoS ONE (5 papers)
- Partner nations
- United StatesChinaUnited Kingdom
In The Last Decade
Matthew E. Burow
203 papers receiving 15k citations
Matthew E. Burow's Hit Papers
Peers
Comparison fields: 5 of 144
- Oncology 4k
- Immunology 3.2k
- Cancer Research 1.7k
- Reproductive Medicine 563
- Health, Toxicology and Mutagenesis 757
Countries citing papers authored by Matthew E. Burow
This map shows the geographic impact of Matthew E. Burow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew E. Burow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew E. Burow more than expected).
Fields of papers citing papers by Matthew E. Burow
This network shows the impact of papers produced by Matthew E. Burow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew E. Burow. The network helps show where Matthew E. Burow may publish in the future.
Co-authors
The 25 scholars most cited alongside Matthew E. Burow, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 211 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival Hit paper breakdown → | 2004 | 4365 |
| 2 | Blockade of B7-H1 improves myeloid dendritic cell–mediated antitumor immunity Hit paper breakdown → | 2003 | 1127 |
| 3 | 2000 | 372 | |
| 4 | 2010 | 300 | |
| 5 | 2003 | 279 | |
| 6 | 2007 | 265 | |
| 7 | 2012 | 229 | |
| 8 | 2003 | 228 | |
| 9 | 2004 | 222 | |
| 10 | 2017 | 214 | |
| 11 | 2003 | 204 | |
| 12 | Differences in susceptibility to tumor necrosis factor alpha-induced apoptosis among MCF-7 breast cancer cell variants. | 1998 | 168 |
| 13 | 2015 | 163 | |
| 14 | 2011 | 159 | |
| 15 | 2010 | 148 | |
| 16 | 2010 | 140 | |
| 17 | 2013 | 138 | |
| 18 | 2000 | 134 | |
| 19 | 2011 | 132 | |
| 20 | 2012 | 131 |
About Matthew E. Burow
Matthew E. Burow is a scholar working on Cancer Research, Oncology, Pathology and Forensic Medicine, Genetics and Molecular Biology, having authored 211 papers that have together received 15.4k indexed citations. Recurring topics across this work include Estrogen and related hormone effects (42 papers), Cancer Cells and Metastasis (33 papers), Phytoestrogen effects and research (29 papers), Breast Cancer Treatment Studies (18 papers), Effects and risks of endocrine disrupting chemicals (17 papers), MicroRNA in disease regulation (11 papers), Melanoma and MAPK Pathways (10 papers) and Sphingolipid Metabolism and Signaling (9 papers). The work is most often cited by research in Oncology (4k citations), Immunology (3.2k citations), Cancer Research (1.7k citations), Reproductive Medicine (563 citations) and Health, Toxicology and Mutagenesis (757 citations). Matthew E. Burow has collaborated with scholars based in United States, China and United Kingdom. Frequent co-authors include John A. McLachlan, Barbara S. Beckman, Bridgette M. Collins‐Burow, Steven G. Elliott, Lyndsay V. Rhodes, Bruce Alan Bunnell, Christopher Bertero Weldon, Stephen M. Boué, Amy L. Strong and Kenneth P. Nephew. Their work appears in journals such as Breast Cancer Research, Journal of Agricultural and Food Chemistry, Breast Cancer Research and Treatment, Cancer Research and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.